Live Breaking News & Updates on Celldex Therapeutics Company Profile

Stay updated with breaking news from Celldex therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Point72 Asset Management L.P. Acquires 1,413,722 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Point72 Asset Management L.P. lifted its holdings in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 105.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,756,122 shares of the biopharmaceutical company’s stock after purchasing an additional 1,413,722 shares during the period. Point72 Asset Management L.P. […] ....

New Zealand General , New Zealand , Elizabeth Crowley , Richardm Wright , Dekabank Deutsche Girozentrale , Wolfe Research , Cantor Fitzgerald , Wellington Management Group , Celldex Therapeutics , Celldex Therapeutics Inc , Charles Schwab Investment Management Inc , Celldex Therapeutics Company Profile , Affinity Asset Advisors , Free Report , Financial Markets , Management Group , Schwab Investment Management , Asset Advisors , Get Free Report , Visit Holdingschannel , Celldex Therapeutics Daily ,

Insider Selling: Celldex Therapeutics, Inc. (NASDAQ:CLDX) SVP Sells 45,000 Shares of Stock

Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) SVP Diane C. Young sold 45,000 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $35.26, for a total transaction of $1,586,700.00. Following the transaction, the senior vice president now owns 2,115 shares […] ....

New York , United States , Dianec Young , Cantor Fitzgerald , Wolfe Research , Charles Schwab Investment Management Inc , York State Common Retirement Fund , Deutsche Bank , Celldex Therapeutics Inc , Principal Financial Group Inc , Swiss National Bank , Celldex Therapeutics , Celldex Therapeutics Company Profile , Get Free Report , Financial Group , National Bank , Schwab Investment Management , Celldex Therapeutics Daily ,

Bellevue Group AG Increases Stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Bellevue Group AG boosted its stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 27.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,416,296 shares of the biopharmaceutical company’s stock after purchasing an additional 516,296 shares during the […] ....

New York , United States , Elizabeth Crowley , Richardm Wright , Swiss National Bank , Bellevue Group , Celldex Therapeutics Inc , Principal Financial Group Inc , Securities Exchange Commission , Celldex Therapeutics , York State Common Retirement Fund , Charles Schwab Investment Management Inc , Deutsche Bank , Celldex Therapeutics Company Profile , Exchange Commission , Cantor Fitzgerald , Free Report , Financial Group , National Bank , Schwab Investment Management , Therapeutics Trading Down , Get Free Report , Visit Holdingschannel , Celldex Therapeutics Daily ,

Elizabeth Crowley Sells 38,597 Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) Stock

Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) VP Elizabeth Crowley sold 38,597 shares of Celldex Therapeutics stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $33.64, for a total transaction of $1,298,403.08. Following the completion of the transaction, the vice president now directly owns 9,074 shares […] ....

Elizabeth Crowley , Headlands Technologies , Cantor Fitzgerald , Celldex Therapeutics Inc , Allspring Global Investments Holdings , Celldex Therapeutics Company Profile , Canada Life Assurance , Celldex Therapeutics , Get Free Report , Global Investments Holdings , Aigen Investment Management , Celldex Therapeutics Daily ,

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Down 5.4%

Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) was down 5.4% during trading on Tuesday . The stock traded as low as $34.87 and last traded at $34.91. Approximately 506,654 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 814,073 shares. The stock had previously closed at $36.92. […] ....

Cantor Fitzgerald , Ameritas Investment Partners Inc , Headlands Technologies , Canada Life Assurance , Celldex Therapeutics Company Profile , Celldex Therapeutics , Allspring Global Investments Holdings , Celldex Therapeutics Inc , Get Free Report , Global Investments Holdings , Ameritas Investment Partners , Investment Partners , Celldex Therapeutics Daily ,